Copd

Whittaker, H. R., Torkpour, A., & Quint, J. (2024). Eligibility of patients with chronic obstructive pulmonary disease for inclusion in randomised control trials investigating triple therapy: a study using routinely collected data. Respir Res, 25, 43. http://doi.org/10.1186/s12931-024-02672-x
View
Tse, G., Emmanuel, B., Ariti, C., Bafadhel, M., Papi, A., Carter, V., et al. (2023). A Long-Term Study of Adverse Outcomes Associated With Oral Corticosteroid Use in COPD. Int J Chron Obstruct Pulmon Dis, 18, 2565-2580. http://doi.org/10.2147/copd.s433326
View
Rothnie, K. J., Numbere, B., Gelwicks, S., Lu, Y., Sharma, R., Compton, C., et al. (2023). Risk Factors Associated with a First Exacerbation Among Patients with COPD Classified as GOLD A and B in Routine Clinical Practice in the UK. Int J Chron Obstruct Pulmon Dis, 18, 2673-2685. http://doi.org/10.2147/copd.s413947
View
Stone, P. W., Osen, M., Ellis, A., Coaker, R., & Quint, J. K. (2023). Prevalence of Chronic Obstructive Pulmonary Disease in England from 2000 to 2019. Int J Chron Obstruct Pulmon Dis, 18, 1565-1574. http://doi.org/10.2147/copd.s411739
View
Wickramasinghe, B., Renzi, C., Barclay, M., Callister, M. E. J., Rafiq, M., & Lyratzopoulos, G. (2023). Pre-diagnostic prescribing patterns in dyspnoea patients with as-yet-undiagnosed lung cancer: A longitudinal study of linked primary care and cancer registry data. Cancer Epidemiol, 86, 102429. http://doi.org/10.1016/j.canep.2023.102429
View
Requena, G., Banks, V., Czira, A., Wood, R., Tritton, T., Wild, R., et al. (2023). Treatment Patterns, Healthcare Utilization and Clinical Outcomes of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting β(2)-Agonist/Long-Acting Muscarinic Antagonist Dual Therapy in Primary Care in England. Int J Chron Obstruct Pulmon Dis, 18, 231-245. http://doi.org/10.2147/copd.s389281
View
Halpin, D. M. G., Rothnie, K. J., Banks, V., Czira, A., Compton, C., Wood, R., et al. (2022). Comparative Adherence and Persistence of Single- and Multiple-Inhaler Triple Therapies Among Patients with Chronic Obstructive Pulmonary Disease in an English Real-World Primary Care Setting. Int J Chron Obstruct Pulmon Dis, 17, 2417-2429. http://doi.org/10.2147/copd.s370540
View
Requena, G., Banks, V., Czira, A., Wood, R., Tritton, T., Wild, R., et al. (2022). Characterization of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting Muscarinic Antagonist/Long-Acting β(2)-Agonist Dual Therapy in a Primary Care Setting in England. Int J Chron Obstruct Pulmon Dis, 17, 1781-1795. http://doi.org/10.2147/copd.s365480
View
Gayle, A., Lenoir, A., Minelli, C., & Quint, J. (2022). Are we missing lifetime COPD diagnosis among people with COPD recorded death?. Bjgp Open. http://doi.org/10.3399/bjgpo.2022.0060
View
Whittaker, H., Rubino, A., Mullerova, H., Morris, T., Varghese, P., Xu, Y., et al. (2022). Frequency and Severity of Exacerbations of COPD Associated with Future Risk of Exacerbations and Mortality: A UK Routine Health Care Data Study. Int J Chron Obstruct Pulmon Dis, 17, 427-437. http://doi.org/10.2147/copd.s346591
View